11.29
+0.09999996(+0.89%)
Currency In USD
| Previous Close | 11.19 |
| Open | 11.45 |
| Day High | 11.49 |
| Day Low | 11.11 |
| 52-Week High | 17.31 |
| 52-Week Low | 7.13 |
| Volume | 20,933 |
| Average Volume | 58,798 |
| Market Cap | 134.85M |
| PE | -2.58 |
| EPS | -4.37 |
| Moving Average 50 Days | 11.33 |
| Moving Average 200 Days | 12.75 |
| Change | 0.1 |
If you invested $1000 in LENSAR, Inc. (LNSR) since IPO date, it would be worth $1,254.44 as of December 10, 2025 at a share price of $11.29. Whereas If you bought $1000 worth of LENSAR, Inc. (LNSR) shares 3 years ago, it would be worth $3,677.52 as of December 10, 2025 at a share price of $11.29.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Alcon Agrees to Acquire LENSAR, Inc.
GlobeNewswire Inc.
Mar 24, 2025 12:00 PM GMT
Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolioNext generation technology will be expanded globally, improving the efficiency of cataract surgery GENEVA and ORLANDO, Fla., March 24,
LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025
GlobeNewswire Inc.
Feb 19, 2025 5:00 PM GMT
ORLANDO, Fla., Feb. 19, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Compa
LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day
GlobeNewswire Inc.
Nov 26, 2024 1:00 PM GMT
ORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced Nick Curtis, C